id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-P-0411-0009,FDA,FDA-2008-P-0411,Novo Nordisk Inc. - Petition for Stay of Action,Other,PSA-Petition for Stay,2008-12-31T05:00:00Z,2008,12,2008-12-31T05:00:00Z,,2013-08-11T02:58:51Z,,0,0,09000064807f9170
FDA-2008-P-0411-0007,FDA,FDA-2008-P-0411,Novo Nordisk Inc. - Petition for Reconsideration,Other,PRC-Petition for Reconsideration,2008-12-31T05:00:00Z,2008,12,2008-12-31T05:00:00Z,,2009-06-18T16:54:55Z,,0,0,09000064807f8de8
FDA-2008-P-0411-0010,FDA,FDA-2008-P-0411,Acknowledgement Letter to Novo Nordisk Inc.,Other,ACK-Acknowledgement Letter,2008-12-31T05:00:00Z,2008,12,2008-12-31T05:00:00Z,,2013-07-28T01:58:06Z,,0,0,09000064807f8e2e
FDA-2008-P-0411-0008,FDA,FDA-2008-P-0411,Acknowledgement Letter to Novo Nordisk Inc.,Other,ACK-Acknowledgement Letter,2008-12-31T05:00:00Z,2008,12,2008-12-31T05:00:00Z,,2013-07-27T22:34:27Z,,0,0,09000064807f919e
FDA-2008-P-0411-0006,FDA,FDA-2008-P-0411,"FDA/CDER to Caraco Pharmaceuticals Laboratories, Ltd. (James F. Hurst) - Petition Approval",Other,PAV-Petition Approval,2008-12-04T05:00:00Z,2008,12,2008-12-04T05:00:00Z,,2009-01-23T15:55:32Z,,0,0,09000064807cd3e5
FDA-2008-P-0411-0003,FDA,FDA-2008-P-0411,"Caraco Pharmaceutical Laboratories, Ltd - Amendment",Other,AMD-Amendment,2008-08-05T04:00:00Z,2008,8,2008-08-05T04:00:00Z,,2013-07-27T22:20:54Z,,0,0,09000064806af9aa
FDA-2008-P-0411-0002,FDA,FDA-2008-P-0411,"Acknowledgement Letter to Caraco Pharmaceutical Laboratories, Ltd.",Other,ACK-Acknowledgement Letter,2008-07-20T04:00:00Z,2008,7,2008-07-20T04:00:00Z,,2008-11-17T19:26:29Z,,0,0,090000648067e39c
FDA-2008-P-0411-0001,FDA,FDA-2008-P-0411,"Caraco Pharmaceutical Laboratories, Ltd. -  Citizen Petition",Other,CP-Citizen Petition,2008-07-20T04:00:00Z,2008,7,2008-07-20T04:00:00Z,,2009-05-01T21:55:41Z,,0,0,090000648067e350